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It is critical for the depressive symptoms of adolescents to be recognized, evaluated, and
treated. Depression can increase the risk for illness and interpersonal difficulties in the future and
affect almost every aspect of an individual’s life. Self-report measures are often utilized to
assess depression, and when these measures are able to effectively detect depression, diagnosis
and treatment are expedited. In order to validate the usefulness and psychometric properties of a
new self-report measure, existing measures are often used as one criterion by which to judge
them. The present study explored concurrent and discriminant validity of a new self-report
depression measure, the Clinical Assessment of Depression (CAD; Bracken & Howell, 2004),
with an established self-report measure, the Reynolds Adolescent Depression Scale (RADS;
Reynolds, 1987). The population for this investigation consisted of 122 adolescents (ages 13 to
18), a group of 99 non-referred and a group of 23 individuals with a primary diagnosis of
unipolar depression. Strong, significant correlations ranging from .70 to .97 were found between
the CAD and the RADS. This study also found that the CAD is a sound instrument that can be
used to discriminate between clinical and non-referred adolescent populations. The CAD
appears to have acceptable validity that supports its use with adolescent populations.
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Review of the Literature
It is imperative for society to gain insight into the disorder of depression. Accurate
identification and treatment of adolescent depression is essential to ensure the well being of
young people. Depression measures that currently exist assess depressive symptoms for specific
age ranges, not across the lifespan. A new depression scale has been developed that assesses
depressive symptoms across the lifespan using one scale. As this new measure is under
development, it is crucial to evaluate it using an established measure for comparison purposes.
As stronger assessment tools are developed, the better the chance of early, accurate identification
and treatment.
This section will provide a review of the literature relevant to this investigation of the
validity of the Clinical Assessment of Depression (CAD; Bracken & Howell, 2004) with the
Reynolds Adolescent Depression Scale (RADS; Reynolds, 1987). First, an overview of child
and adolescent depression will be provided including incidence, symptomology, and diagnostic
criteria. Next, the psychometric assessment of depression in children and adolescents will be
discussed. Lastly, the purpose of the present investigation will be presented.
Depression in Adolescents
Depression is a psychological disorder that is often overlooked among child and
adolescent populations. Health care providers and family members of children and adolescents
often view possible indicators of depression expressed by young people as typical mood swings
and, as a result, the disorder remains under-diagnosed and untreated (Evans, Velsor, &
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Schumacher, 2002; National Institute of Mental Health [NIMH], 2000). Children and
adolescents commonly find it difficult to identify and express the internal emotional state they
are in, but often display classic symptoms such as low self-esteem, guilt, loss of interest in
school activities, decreased school performance, and boredom (NIMH, 2000). It is critical for
the depressive symptoms of adolescents to be recognized, evaluated and treated, as depression
can increase the risk for illness and interpersonal difficulties in the future and affect almost every
aspect of that individual’s life (Evans et al., 2002; Stanard, 2000).
The body of research concerning childhood and adolescent depression has increased over
the past two decades and a knowledge base regarding childhood depression has consequently
emerged. Prevalence rates for major depression are comparable to that of adults, making
depression a major health problem among youths. The incidence of depression among youth in
the United States ages 9-17 is estimated to be around five percent with between 1.5% and 4.7%
being diagnosed with Major Depressive Disorder (Fritz, 1997; Pullen, Modrcin-McCarthy, &
Graf, 2000; Stanard, 2000). The prevalence of depressive disorders differs in countries
throughout the world. Past research indicates percentages ranging from 11.7% of adolescents in
East Germany to 40% of Bulgarian adolescents. In the United States, Canada, and Britain, the
prevalence was found to be around 10% and in Poland, the percentage was around 30 (Boyd,
Gullone, Kostanski, Ollendick, & Shek, 2000). While prevalence rates may vary across
countries, depression appears to be a universal construct of significant concern in children and
adolescents.
Gender and depression. When looking at the prevalence rates of depression by gender,
an equal number of boys and girls suffer from depression prior to adolescence. The percentage of
adolescent boys identified as experiencing a depressed mood is between 20 and 35 percent; for
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adolescent girls, the percentage rate is between 25 and 40 percent (Peterson et al., 1993).
According to Reynolds (1992), 8 to 18 percent of school-aged youth have experienced a clinical
level of depression.
During adolescence, however, rates of unipolar depression (major depressive disorder,
dysthymic disorder, or depressive disorder not otherwise specified) have been found to be higher
for girls than for boys (Herson & Ammerman, 2000; Marcotte, Fortin, Potvin, & Papillon, 2002;
Rutter, Graham, Chadwick, & Yule, 1976). In a study comparing female and male mean scores
on the Reynolds Adolescent Depression Scale (RADS) and the Beck Depression Inventory
(BDI), Baron and Campbell (1993) examined whether females continue to exhibit higher mean
scores on discriminating items. It was found that females do in fact have higher mean scores on
these items. This supports the view that females characteristically report more depressive
symptoms than males (Baron & Campbell, 1993).
Diagnostic criteria. In determining a diagnosis of depression for adolescents, the criteria
set forth by the Diagnostic and Statistical Manual of Mental Disorders-4th Edition Text Revision
([DSM-IV-TR] American Psychiatric Association [APA], 2000) must be met. The DSM-IV-TR
consists of three diagnostic categories for unipolar depressive disorders: major depressive
disorder, dysthymic disorder, and depressive disorder not otherwise specified.
As a severe form of depression, Major Depressive Disorder is characterized by one or
more Major Depressive Episodes. These episodes last at least two weeks and consist of
depressed mood and loss of interest in most all activities. The individual must also suffer from at
least four additional symptoms of the following list: “changes in appetite or weight, sleep, and
psychomotor activity; decreased energy; feelings of worthlessness or guilt; difficulty thinking,
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concentrating, or making decisions; or recurrent thoughts of death or suicidal ideation, plans or
attempts” (APA, 2000, p. 356).
A second unipolar depressive diagnostic category is Dysthymic Disorder. This form of
depression consists of a less severe symptom pattern than major depression; however, the
symptoms are chronic in that they are experienced for at least one year. With children and
adolescents, symptoms must last at least one year and must include two or more of the following:
irritability, poor self-esteem, poor social skills, feelings of hopelessness, and impaired school
performance (APA, 2000).
The third diagnostic category involving unipolar depression in the DSM-IV-TR is
Depressive Disorder Not Otherwise Specified. This form of depression includes depressive
features consistent with that required to diagnose major depression or dysthymia, yet the
symptom pattern does not meet the criteria for any other Depressive Disorders in severity,
quantity, or duration. When there is inadequate or contradictory information, this form of
depression may be used for diagnosis (APA, 2000).
Adolescent symptoms. While the same criteria are required for a diagnosis of Major
Depressive Disorder in adolescents as in adults, the symptoms are commonly presented
differently (Mash & Wolfe, 2002; Mellin & Beamish, 2002; Oster & Montgomery, 1995;
Stanard, 2000). Adolescents experiencing depressive disorders tend to exhibit more
helplessness, fatigue, despair, lack of pleasure, suicidal thoughts, hypersomnia, and variations in
weight than depressed adults (Evans et al., 2002; NIMH, 2000; Stanard, 2000). Depressive
Disorders during adolescence also tend to be more episodic, with phases of depression, followed
by phases of better functioning (Mellin & Beamish, 2002). Impairments in academic
performances and relationships with others are often noted in adolescents experiencing clinical
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levels of depression (Evans et al., 2002; Mellin & Beamish, 2002). Adolescent depression may
also be expressed in ways that do not resemble depressive symptoms, such as behavior problems,
family problems, substance abuse, or rebellion (Mellin & Beamish, 2002). There are also gender
differences in the expression of depressive symptoms. Males tend to exhibit more irritability,
work inhibition, sleep disturbance, and social withdrawal while females tend to exhibit more
body image distortion, loss of appetite, sadness, dissatisfaction, and weight loss (Baron &
Campbell, 1993).
Assessment of Depression
Use of self-report scales. The diagnosis of depression is reached after a
comprehensive assessment in which information about the individual’s symptoms and
behavior/behavior patterns are obtained. Recommended practices in diagnosis are to gain such
information primarily through a multimodal assessment approach utilizing clinical/diagnostic
interviews with the child/adolescent or their parent(s), documentation of the child’s/adolescent's
behavior over time through use of behavior checklists, and self-report measures to assess
symptom pattern and severity. While all of these methods are important to use in a thorough
assessment, self-report measures are frequently utilized to assess depression and are the focus for
this investigation (Wright-Strawderman, Lindsey, Navarrete, & Slippo, 1996).
Self-report measures are frequently used in social-emotional assessment (Marcotte et al.,
2002; Merrell, 1999; Reynolds, 1990; Stanard, 2000; Wright-Strawderman et al., 1996). The
utilization of such measures enables individuals to report their own internal thoughts, feelings,
and emotions. This allows for better first-hand information of an individual's internal experience
of depression than what could be obtained from a third party’s observation of symptom patterns.
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Objective self-report measures are often standardized instruments. They require the
completion of questions or items concerning an individual's perception of his or her social or
emotional behavior and answers are compared to a population sample. It has been proposed by
Martin (1988) that self-report measures must have four essential characteristics present before
being considered as objective measures: (a) adequate test-retest reliability, (b) standardized
procedures, (c) provide normative data for comparison, and (d) adequate validity. It is important
to address Martin’s characteristics in the test development process.
Types of rating scales. Self report rating scales vary on the scope of the behaviors or
symptomology covered. There are some self-report measures available that deal with a broad
range of symptomology, however there are also measures available that focus specifically on
depressive symptomology, a narrow range of symptomology. Such standardized measures that
specifically assess adolescent depression include the Beck Depression Inventory-II (BDI-II;
Beck, Steer, & Brown, 1996) and the Reynolds Adolescent Depression Scale (RADS; Reynolds,
1987). There are other measures that assess a broad range of symptomology, including
depression (e.g., Behavior Assessment System for Children, Child Behavior Checklist), that are
helpful as a screening device to provide depressive symptom information, however the RADS
and the BDI-II provide more systematic and specific coverage of the symptoms of depression.
The Reynolds Adolescent Depression Scale (RADS) was developed by William M.
Reynolds in 1986. This was the first depression scale developed specifically for use with
adolescents and it was developed by selecting items based on symptomology described by the
DSM-III for Major Depression and Dysthymic Disorder. It is an accepted measure among
clinicians (Merrell, 1990) and assesses depressive symptoms in adolescents ages 13 through 18.
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The RADS can also be used for individuals outside of this age range who are in junior or senior
high school settings.
Martin’s evaluation criteria for objective self-report measures can be used to evaluate the
RADS (1988). There are four essential characteristics that a self-report measure should possess
in order to be considered a good self-report measure. The RADS has an established test-retest
reliability ranging from .63 to .80 from studies that have been conducted (Platt, 1999; Reynolds
1987). Standardized administration procedures are utilized in the RADS. Presentation of test
items is done in a consistent manner and the responses are compared to responses of other
individuals. The RADS also provides normative data that allows scores to be compared to a
larger group of individuals and it has established validity (Platt, 1999; Reynolds 1987). Based
on these criteria, the RADS is an established self-report measure that provides reliable, norm
referenced, valid information to the professionals who utilize it.
The Clinical Assessment of Depression (CAD), developed by Bracken and Howell, is an
instrument that is under development by Psychological Assessment Resources (PAR). It was
developed to answer the question as to whether or not depressive symptoms are consistent across
the age range from childhood through adulthood. The existing published measures of depression
are designed either for adult or child populations. The CAD was developed to assess depression
among children, adolescents, and adults using a single form.
As the CAD is currently in development, only limited information is available. However,
this measure has a test-retest reliability ranging from .81 to .87 and the author reports there is
evidence for adequate validity. The CAD is a standardized measure yielding age-related scores
for the total measure and four subscales. The presentation of test items is done in a consistent
manner and item responses can be compared to responses of other individuals (B. A. Bracken,
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personal communication, March 25, 2004). The CAD appears to be a promising measure for use
in the assessment of depression.
Purpose of Present Investigation
Self-report measures play an important role in the assessment of depression. Due to the
internalizing nature of depression, an individual is more in-tune to his or her own thoughts and
feelings than what a third party can ascertain through observation (Merrell, 1999; Reynolds,
1990; Stanard, 2000). When depression measures are able to effectively detect depression,
diagnosis and treatment can be expediated. In order to validate the usefulness and psychometric
properties of new measures, existing measures are one criterion by which to judge new
instruments. According to the Standards for Educational and Psychological Testing (AERA,
APA, & NCME, 1999), such investigations should be conducted prior to use in the field. As
noted previously, the RADS is considered to be a psychometrically adequate instrument that is
used to assess depression in adolescents. And it is reasonable to use the RADS as a criterion
measure for establishing validity of similar measures under development. The purpose of this
investigation is to explore the concurrent validity of a measure under development, the Clinical
Assessment of Depression (CAD), with an existing proven measure, the Reynolds Adolescent
Depression Scale (RADS). Classification efficacy of the CAD for diagnosing depression will
also be explored. The hypotheses for this investigation are as follows.
1. The CAD total score, and subscales will evidence strong concurrent validity with the
RADS total score for the combined total sample.
2. The clinical group will evidence significantly higher mean scores on the CAD
than the non-referred group and higher mean scores on the RADS than the nonreferred group.
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In addition to the hypotheses above, the classification efficacy of the CAD was examined using
the RADS as the criterion measure.

Method
Participants
The sample consisted of adolescents residing in south central Kentucky (ages 13
to 18) who have either been diagnosed with Major Depressive Disorder, Dysthymia, or
Depressive Disorder NOS (clinical group) or who have no diagnosis (non-referred group). One
hundred twenty two adolescents (ages 13 to 18), 57 males and 65 females comprised the clinical
(n=23) and non-referred groups (n=99).
The clinical sample consisted of individuals diagnosed with unipolar depression
diagnoses including: Major Depressive Disorder (n=5), Dysthymia (n=2), or Depressive
Disorder, NOS (n=14) according to DSM-IV-TR criteria (APA, 2000). One participant was
diagnosed with Major Depressive Disorder as a secondary diagnosis, and one participant was
diagnosed with Cyclothymic Disorder. The mean age for the clinical sample was 15.0 and
consisted of 91.3% Caucasian participants and 8.7% minority participants.
The non-referred group was composed of individuals from a high school in south central
Kentucky. Mean age for the non-referred group was 15.4 years. The non-referred sample
consisted of 91.9% Caucasian participants and 8.1 percent minority participants. The total
sample combining both groups consisted of 91.8% Caucasian and 8.2% minority participants.
Instruments
Reynolds Adolescent Depression Scale (RADS). The Reynolds Adolescent Depression
Scale is a brief, 30-item, self-report measure for adolescents ages 13-18 that can be administered
individually or in a group or orally to the reading disabled and takes about 10 minutes to
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complete. It requires a response by the adolescents that indicates how they usually feel. The
RADS is used as a screening measure for identifying depressive symptoms in school and clinical
populations. It is used for research on depression and has subscales that evaluate Dysphoric
Mood, Anhedonia/ Negative Affect, Negative Self-Evaluation, and Somatic Complaints. The
RADS is also used for evaluation of treatment outcomes (Reynolds, 1987).
According to the RADS Professional Manual, the internal consistency of the
standardization sample for the RADS ranged from .909 to .939, with a total sample alpha of .922
and split-half reliability with the same sample was .91. Other internal consistency data obtained
found results similar to these (Merrell, 1999). The results of three studies that were conducted to
examine test-retest reliability obtained coefficients of .80, .79, and .63. Data support that this
test is a reliable measure.
Content validity assesses whether or not a test measures adequately a particular domain,
such as depression, in this case. Content validity was found by looking at the similarity of item
content with depressive symptomology and item total scale correlations indicating item
consistency. Using a standardization sample of 2,296 adolescents, item total correlation
coefficients were mainly in the .50s and .60s with median correlation being .53 (Platt, 1999).
Using a sample of 111 high school adolescents, concurrent validity with the Hamilton
Depression Rating Scale (HDRS) was found to be .83, which indicates a strong relationship
between the two measures in their ability to assess depression (Davis, 1990; Platt, 1999). A
sample of 1054 adolescents (age 12-14) produced a correlation of .70 between the RADS and the
Children’s Depression Inventory (Reynolds, 1987). Brown, Overholser, Spirito, and Fritz’s
study (as cited in Reynolds, 1992) reported a correlation of .64 in a sample of adolescent suicide
attemptors. Several supporting studies of construct validity were provided in the RADS manual
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and successive studies have been published supporting its validity (Merrell, 1999). When
compared to other self-report measures of depression, the following correlations were reported:
between the RADS and the Beck Depression Inventory correlations ranged from .68 to .76;
correlations between the RADS and the CES-D (the Center for Epidemiological Studies
Depression Scale) ranged from.74 to .76; the correlation between the RADS and the Self Rating
Depression Scale was .72 (Davis, 1990; Platt, 1999; Reynolds, 1987).
Platt (1999) describes the RADS as possessing several strengths. It’s attractive
appearance and inviting front cover give the test examinee a sense of ease when describing their
feelings. The instructions were found to be direct and easily understandable, and scoring of this
instrument was found to be quick and easy (Platt, 1999). The RADS also makes validity checks
to account for truthfulness of respondents. Supporting previous research also indicates that the
RADS manual is well written and strongly documented (Merrell, 1999). Merrell (1999) supports
that the RADS is gaining acceptance throughout the clinical and research communities and is a
strong supplement to the adolescent self-report instrumentation that is being used.
Weaknesses mentioned by Pratt (1999) include the limited sample used in
standardization. While a large sample was used, it did not take into account racial diversity or
more than one geographic location. The test-retest reliability dropped over one year’s time. This
drop could have been influenced by external factors, for example therapeutic interventions or
internal factors.
Clinical Assessment of Depression (CAD). The CAD (Bracken & Howell, 2004) is
currently in development by Psychological Assessment Resources. It is a 50-item scale that
takes approximately 10 minutes to complete. The age range for this scale is 9 to 79 years. The
CAD assesses depressive symptomology on four subscales: Depressed Mood, Anxiety/Worry,
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Diminished Interest, and Cognitive and Physical Fatigue. Items in these categories were
developed using wording and content appropriate for all ages.
Although the CAD is currently under development, pre-publication psychometric data
were obtained (B. A. Bracken, personal communication, March 23, 2004). CAD Total Scale
score reliability ranged from .96 to .98 and vary little by age, race, and gender. Subscale
reliabilities are as follows: Depressed Mood subscale ranged from .95 to .97; Anxiety/Worry
subscale ranged from .82 to .90; Diminished Interest subscale ranged from .79 to .92; and
Cognitive and Physical fatigue subscale ranged from .79 to .91. Variation of these subscales is
largely due to sample size. Test-retest reliability for the Total Scale score ranged from .81 to .87.
Concurrent validity was established through correlations between the CAD Total Scale score and
the Beck Depression Inventory (BDI-II; r = .71) and between the CAD Total Scale score and the
RADS (r = .64). The author reported confirmatory factor analyses support the four subscales
structure of the instrument.

Procedure
Clinical group participants were recruited through private clinicians and psychiatric
hospitals. Once permission was obtained to solicit participants from these treatment providers,
these providers were given packets and directions for distributing forms to parents/guardians.
Each parent/guardian was given a packet containing a letter including the description of the study
and an invitation to participate, two parent consent forms (WKU and PAR), a release of
information form, an instruction sheet, an adolescent assent form, and the three depression scales
(CAD, BDI-II, and RADS; see Appendix A for forms). Data collection for this study overlapped
with another investigation that necessitated the BDI-II be included in the packet. Parents were
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asked to complete the two consent forms and the release of information form. The adolescents
were asked to complete the assent form and the three depression scales. Upon completion of the
three depression scales and the consent and assent forms, participants were asked to place and
seal the scales in one envelope and the consent and assent forms in a separate envelope. The
parent/guardian or participant then returned both packets to their clinician from whom the
conductor of this study retrieved them. Participants were given a local fast food restaurant
coupon that did not exceed $2.00 in value for their participation. The researcher provided these
coupons to the therapist who distributed them. The researcher of this study then asked the
therapist to complete the Clinician’s Record Form after a signed release form was obtained from
the parent/guardian (see Appendix A).
Subjects comprising the non-referred group were solicited from a local high school. For
data collection at the high school, an introductory letter and consent form were sent home with
one randomly selected 9th, 10th, 11th, and 12th grade classroom in a public high school in south
central Kentucky (100 students; see Appendix B for forms). Students who returned forms to the
school received a local fast food restaurant coupon that did not exceed a $2.00 value. A coupon
was given for returning the consent form whether or not consent was granted. The students for
whom parental consent was obtained were asked to sign an assent form and complete three
measures during school hours. An appropriate time for completion of questionnaires, which was
approximately 25 minutes, was determined between the researcher and the students’ teacher. A
coding system was used so that a student could be identified in the event of significant responses
indicating depression or suicidal ideation. Parents/guardians were notified by the researcher
when significant ratings were obtained in the non-referred group. Names were kept separate
from all forms, with no names appearing on the forms. All procedures for this study were
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approved by Western Kentucky University’s Human Subjects Review Board in April 2003 (see
Appendix C).

Results
This researcher had three purposes: (a) to examine the relationship between the CAD and
the RADS, (b) to determine whether group differences existed between the clinical group and the
non-referred group on the CAD and the RADS, and (c) to explore the hit rate or classification
consistency when using the RADS as the criterion measure.
The sample consisted of 122 adolescents ages 13 to 18 from south central Kentucky (57
males and 65 females). Twenty-three comprised the clinical group (10 males and 13 females);
ninety-nine comprised the non-referred group. Table 1 provides the mean score (M), the
standard deviation (SD), and the standard error of the mean (SEM) for the raw scores on each
measure for the clinical and non-referred groups.
To examine the relationship between the CAD and the RADS, Pearson product-moment
correlation coefficients were computed for the total raw scores for each scale and for each
subscale of the CAD (Depressed Mood, Anxiety/Worry, Diminished Interest, and Cognitive and
Physical Fatigue) with the RADS total score. Using the Bonferroni approach to control for Type
I error across the 12 correlations, a p value of less than .003 was established for significance.
The results of the correlational analyses are presented in Table 2. All of the 15 correlations were
statistically significant. Using Cohen’s (1988) effect sizes, the correlations obtained were
classified within the strong range. The results suggest strong concurrent validity between the
total score on the RADS and the total score on the CAD, as well as between the RADS and each
subscale on the CAD.
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Table 1
Sample Descriptive Statistics for the Raw Scores on the RADSa and the CADb
RADS
_______________________

CAD
_______________________

N

M

SD

SEM

N

M

SD

SEM

Male

46

56.20

17.37

2.56

47

97.34

29.81

4.35

Female

52

65.62

18.73

2.60

52

107.12

29.29

4.06

Total

98

61.19 18.62

1.88

99

102.47 29.80

2.99

Male

10

57.90

11.80

3.73

10

106.40

26.07

8.25

Female

13

80.85

16.97

4.71

13

138.77

27.33

7.58

Total

23

70.87 18.69

3.90

23

124.70 30.90

6.44

Male

56

57.05

16.43

2.20

57

101.87

29.18

3.86

Female

65

73.24

19.27

2.40

65

122.95

31.40

3.90

Total

121

63.03

18.94

1.72

122

106.66

31.12

2.82

Sample
Non-referred

Clinical

Total Sample

Note. Clinical sample consisted of individuals diagnosed primarily with Major
Depressive Disorder, Dysthymia, or Depressive Disorder, NOS.
a

Reynolds Adolescent Depression Scale. bClinical Assessment of Depression.
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Table 2
Correlations of RADSa Total Score with CADSb Total Score and Scales
Subscale

1

2

3

4

5

6

1. CAD Total Score

-

.97*

.93*

.90*

.86*

.88*

2. CAD, Depressed Mood

-

-

.86*

.84*

.74*

.86*

3. CAD, Anxiety/Worry

-

-

-

.78*

.78*

.84*

4. CAD, Diminished Interest

-

-

-

-

.77*

.78*

5. CAD, Cognitive and Physical

-

-

-

-

-

.70*

-

-

-

-

-

-

Fatigue
6. RADS Total Score

a

Reynolds Adolescent Depression Scale. bClinical Assessment of Depression.

* p < .004
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To determine whether group differences existed between the clinical and non-referred
groups, independent samples t tests were conducted to see how each of the two scales (RADS
and CAD) could distinguish between the two groups (clinical and non-referred) mean scores.
Levene’s Test for the Equality of Variances was computed due to the number of group
participants being unequal. All significance levels for the equality of variances test were found
to be above .05. Therefore the t test results were interpretable. The tests were significant, t(119)
= -2.24, p = .027 for the RADS, and t(120) = -3.2, p = .002 for the CAD. The results support
the hypothesis that the clinical group will evidence higher scores on each of the two scales than
the non-referred group. Participants in the clinical group displayed higher scores on both scales
than participants in the non-referred group.
Classification efficacy of the CAD was explored using the RADS as the criterion
measure. Bracken recommends using a T-score of 60 as the cutoff score for distinguishing
between depressed and non-depressed individuals (B. Bracken, personal communication, March
23, 2004). Using the RADS cutoff raw score of 77, and comparing CAD categories of depressed
and non-depressed to actual RADS findings, a 2 x 2 contingency table was computed (Table 3)
for the total sample. An examination of the association between the RADS cutoff score and the
CAD cutoff score resulted in a χ2 = 51.74, (p < .000). An examination of cell proportions
indicated that the CAD and the RADS, as to their diagnostic category for the total sample,
consistently identified 84% of the adolescents.
Further contingency tables were computed in order to understand the classification
efficacy of the CAD and the RADS using group membership (clinical and non-referred) as the
criterion. Table 4 shows a contingency table for the CAD and group membership. The hit rate
for the CAD was found to be 68%. There were 25% false positives and 7% false negatives.
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Table 3
Total Sample Classification Table between RADSa Cutoff and CADb Diagnosis of Depression

CAD Classification
__________________________________

RADS Classification

Non-depressed

Depressed

Total

Non-depressed

63%

16%

79%

(n=77)

(n=19)

(n=96)

1%

20%

21%

(n=1)

(n=25)

(n=26)

64%

36%

100%

(n=78)

(n=44)

(n=122)

Depressed

Total

χ2 = 51.74
a

Reynolds Adolescent Depression Scale; depression classification based on raw score

> 77.
b

Clinical Assessment of Depression; depression classification based on T-score > 60.
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Table 4
Classification Table between CADa Diagnosis of Depression and Group Membershipb

CAD Classification
__________________________________

Group Membership

Non-Significant

Depressed

Total

Non-Referred

57%

25%

81%

(n=69)

(n=30)

(n=99)

7.4%

11.5%

19%

(n=9)

(n=14)

(n=23)

64%

36%

100%

(n=78)

(n=44)

(n=122)

Clinical

Total

χ2 = 7.56
a

Clinical Assessment of Depression; depression classification based on T-score > 60.

b

Non-referred consisted of 99 adolescents 13-18 years of age; clinical sample consisted of 23

individuals, 13-18 years of age, diagnosed primarily with Major Depressive Disorder,
Dysthymia, or Depressive Disorder, NOS.
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The χ2 statistic was significant, χ2 = 7.56, (p < .006) indicating the cell proportions are not a
chance occurrence. Table 5 shows a contingency table for the RADS and group membership.
The hit rate for the RADS was found to be 73%, with 15% false positives and 12% false
negatives identified. The χ2 statistic was significant, χ2 = 3.07, (p < .08) indicating the cell
proportions are not a chance occurrence.
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Table 5
Classification Table between RADSa Diagnosis of Depression and Group Membershipb

RADS Classification
__________________________________

Group Membership

Non-Significant

Depressed

Total

Non-Referred

66%

15%

81%

(n=81)

(n=18)

(n=99)

12.3%

6.6%

19%

(n=15)

(n=8)

(n=23)

79%

21%

100%

(n=96)

(n=26)

(n=122)

Clinical

Total

χ2 = 3.07
a

Reynolds Adolescent Depression Scale; depression classification based on T-score > 77.

b

Non-referred consisted of 99 adolescents 13-18 years of age; clinical sample consisted of 23

individuals, 13-18 years of age, diagnosed primarily with Major Depressive Disorder,
Dysthymia, or Depressive Disorder, NOS.

Discussion
The current study expected to find that there is a significant positive correlation
between the CAD and the RADS for the clinical and non-referred group participants. Total
scores were expected to yield moderate to high correlations between the two scales. In addition,
the CAD was expected to discriminate between clinical and normal groups of adolescents. On
the CAD and the RADS, total scores were to yield significantly higher scores in the clinical
population than in the normal population. In addition, classification efficacy was to be
examined.
The first objective of this study was to determine how concurrently the CAD and the
RADS could identify depressive symptoms in both the clinical and non-referred sample.
Pearson product moment correlations computed for the RADS total score, CAD total scale score,
CAD Depressed Mood scale, CAD Anxiety/Worry scale, CAD Diminished Interest scale, and
CAD Cognitive and Physical Fatigue scale were significant and positive ranging from .70 to .97.
Using Cohen’s (1988) effect sizes to determine the strength of the correlation, all correlations are
considered to be strong, accounting for 49% to 94% of the variance between the two measures.
The weakest correlation (.70) was between the RADS total score and the CAD Cognitive and
Physical Fatigue scale score; the strongest correlation (.97) was between the CAD total score and
the CAD Depressed Mood scale score. The findings support the hypothesis that the CAD will
evidence strong concurrent validity with the RADS.
The next objective of this study was to determine if the CAD could discriminate between
the clinical and non-referred population. The RADS was used as the criterion measure due to its
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empirically validated ability to detect depressive symptoms. Independent samples t tests were
computed to examine mean group differences (clinical versus non-referred) of the two scales
(RADS and CAD). The t test for each measure was significant. The t test for the RADS scores
indicated that the samples can be discriminated on the basis of mean scores. The t test for the
CAD indicates that the clinical group had higher mean scores than the non-referred group. The
findings support the hypothesis that the clinical group will evidence higher mean scores on the
two scales than the non-referred group.
The final objective of this study was to examine the classification efficacy of the CAD
using the RADS as the criterion. Using a 2 x 2 contingency table, the hit rate for the total sample
was found to be high at 84%. However, 16% were identified as false positive and one percent as
false negative. A false negative occurred when the RADS identified a person as depressed and
the CAD identified that person as not depressed; this is considered a more liberal classification.
A false positive occurred when the RADS identified an individual as not depressed and the CAD
identified that same person as depressed; this can be considered a conservative classification. A
false positive, while it is an error, is more conservative in diagnosing depression. When using
group membership as a criterion, the CAD produced a hit rate of 68%, with 25% false positives
and 7% false negatives. The RADS produced a hit rate of 73%, with 15% false positives and
12% false negatives. There are a few explanations that may account for these discrepancies.
First, there was a small number of clinical participants (n=23) in comparison to the non-referred
participants (n=99). A higher hit rate was found in the non-referred population, and this is likely
due to the larger sample size. Secondly, major depression is not a stable symptomology. When
the clinical participants were diagnosed with depression, the symptoms may have been much
more severe than they were at the time of participation in this study. The researcher was not
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aware of the length of time the clinical participants had been in treatment, and some participants
were currently on medication at the time of participation. Depression exists on a continuum, and
this helps to explain why there would be an expected amount of variation in the severity of the
ratings made by the clinical participants.
Limitations
While valuable information can be obtained from this study, there are limitations that
could affect the interpretation of the results. Low sample size, particularly in the clinical
population, may have limited the amount of information that was gathered. Also, clinical
participants were recruited through both inpatient and outpatient facilities, which may explain
some of the discrepancy in classification within that sample.
A threat to the internal validity of the study was the differential selection of the
participants. The clinical participants were all receiving services; it is possible that there was
something unique about the clinical sample (being in treatment) that affected the results. There
were threats to the external validity of the study as well. The clinical sample was not completely
homogenous in that it was comprised of three types of diagnoses and had other diagnoses
secondary to depression and one participant had depression as a secondary diagnosis. A more
homogeneous sample would increase confidence in findings. Another external threat is that the
study relied on participants in treatment to represent the clinical population; depressed
individuals who did not seek treatment were not represented in this study. Therefore, it is
difficult to say how generalizable the findings of this study are. A final external threat affects
data collection. Data were collected in one geographic region (south-central Kentucky), and
while the study sample’s ethnicity was representative of the region (7% minority), it is not
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typical of the United States as a whole. Therefore, generalizability to other geographic regions
may not be as valid.
Implications
Practical implications. Findings of the current study have strong implications for the
field of psychology. As depression measures are limited for child and adolescent populations, it
is important that additional measures be established. The current study has provided evidence for
the validity of a newly developed depression scale, the CAD, with adolescents and expanded the
knowledge base of adolescent depression measures. With prevalence rates of childhood
depression on the rise and the high need for identification of depression in adolescents, it is
imperative that valid, reliable, and standardized measures be established and made accessible.
Measures that can adequately identify and diagnose depressive symptoms will increase the
likelihood of accurate treatment.
Recommendations for future research. The present study focused on convergent validity
with the CAD and RADS, which are two instruments designed specifically for depressive
symptom identification. Further investigation with the CAD should explore it’s use with
inpatient and outpatient settings, individuals over the course of treatment and more
homogeneously defined clincal groups. In addition, further investigations might explore
divergent validity of the CAD with measures that assess a wider range of clinical symptoms,
including internalizing behaviors such as depression, but also focus on a wider assessment of
overall symptoms. Further evidence of validity should be explored through factor analysis. This
would help to substantiate the subscale structure of the CAD.
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Dear Parent/Guardian,
Your child is invited to participate in a study looking at the usefulness of 3 measures of social and
emotional well-being. This study is being conducted by Shanna Bowers, Brooke Wootton and Dr.
Elizabeth Jones of Western Kentucky University in cooperation with your child’s clinician. The
results of the study will be used to determine how well these 3 instruments measure social and
emotional well-being in adolescents.
In addition, the data from this study will be used to evaluate a new instrument that measures social
and emotional well-being. Such data can provide information about the new instruments’ usefulness
and ability to measure what it sets out to measure. If you agree to allow your child’s responses to be
used in this evaluation process, there is a separate consent form included in this packet that requires
your signature. This form will be returned to the test publisher.
Upon your consent and your child’s assent, your child will be asked to complete 3 questionnaires
concerning their thoughts, feelings, and emotions as they relate to their day-to-day functioning. It
will take approximately 25 minutes to complete and this may be done before or after your child’s
therapy sessions. You will also be asked to complete a release of information form to allow your
child’s therapist to release diagnosis, medication, and family history information. This information
will only be used by the researchers to insure that research requirements are met. Your child’s name
will not appear on this form. For your child’s participation in this study he or she will receive a local
fast food restaurant coupon that will not exceed a $2.00 value.
Your consent and your child’s participation are completely voluntary. At any time withdrawal from
the study is possible. If you do not consent for your child to participate, it will have no negative
outcomes for you or your child and will not affect the relationship with the clinician. There are no
physical risks involved in filling out the questionnaires. However, answering the items on the
questionnaires may cause your child to feel some emotional discomfort, due to the nature of the
questions asked about your child’s behavior. All information collected in this study will be kept
strictly confidential and will be accessible only to project staff. However, all packets will be coded
to allow for identification only if an individual's responses indicate a threat to self or others on the
questionnaires. Researchers must by law report this information to your child’s clinician and you
will be immediately informed.
The procedures in this study have been reviewed and approved by the Western Kentucky University
Human Subjects Review Board. If you have questions about the study you may contact Dr. Elizabeth
Jones by phone at (270) 745-4414. We hope that both you and your child agree to take part in our study.
To indicate your consent for participation please complete and sign the attached form, have your child
complete the questionnaires, and return the packet to your child’s clinician.
Sincerely,

Elizabeth L. Jones
Associate Professor of Psychology

Shanna Bowers
Brooke Wootton
School Psychology Graduate Students
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Participation Consent Form
Child’s Age ____

Child’s Gender __ M __F

Child’s Race/Ethnicity________

I have read the information provided concerning this study. I give consent for my child to
participate in this study conducted by Shanna Bowers, Brooke Wootton, and Dr. Elizabeth Jones
of Western Kentucky University. I understand that I may withdraw from the study at any time
without penalty.
_____ I DO give consent for my child to participate in this study.
_____ I DO NOT give consent for my child to participate in this study.
Parent/Guardian Signature ______________________________

Date __________
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PARENT/GUARDIAN CONSENT FORM
Research Participation in a Behavioral Study

General Information and Purpose
My child:____________________ has been asked to participate in a research study being conducted by
PAR, Inc., a developer and publisher of educational and behavioral assessment tools. The purpose of
the study is to evaluate a new test designed to identify behavioral problems in adolescents. I have been
asked to participate in this study because I am the parent of a child (ages 2 to 18 years); if my child is
between 8 and 18-years-old, he or she has also been asked to participate.

What is involved in my child’s participation?
If I agree (and give consent for my child) to participate in this study, my child will complete one or more
questionnaires that ask about my child’s academic, social, and personal behaviors. Children
questionnaires take from 15 to 30 minutes to complete.

Risks
There is no physical risk involved in filling out the questionnaires. Answering the questions on the
questionnaires may cause my child to feel some emotional discomfort, due to the nature of the questions
asked about my child’s behavior.

Benefits
The results of this study may be of benefit in the future to children with behavioral problems and the
professionals who evaluate and treat them. There is no immediate benefit to my child for their
participation, however they may benefit in the event that they indicate suicide or harm to others. If
such indicators are present, they will be identified and I will be identified immediately.

Confidentiality
My child’s answers on the questionnaires are strictly confidential and anonymous. I will not be
asked to put my child’s name on the questionnaires. Only the primary researchers or their
designees will have access to my child’s confidential survey responses. However, the packets
will be coded to allow for identification only if my child’s responses indicate suicide or harm to
others. By law researchers must report this information to you immediately.

Right to Withdraw or Decline to Participate
My child’s participation in this study is completely voluntary. He/she may choose not to participate, or to
withdraw from participation at any time without penalty.
I attest that I have read and understand all of the above pertaining to my child’s participation in this study,
and that all of my questions about the study have been answered to my satisfaction. I hereby give my
informed consent for my child to participate in this research study.
____________________________ ____________________________
Parent’s Name (please print)
Parent’s Signature

_________
Date

If you have any questions regarding this research study or participation in it, please call Michelle Owens or Dr. Mario Rodriguez (Project Director) at 1-866-PARDATA or 1-800-331-TEST. PAR, Inc./16204 N. Florida Avenue, Lutz FL 33549/Tel (813)968-3003/Fax (813)968-4684
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Release of Information
CONCURRENT VALIDITY STUDY OF ADOLESCENT DEPRESSION MEASURES

(1) TO:_______________________________

(2) DATE:__________________

_______________________________
_______________________________
(3) RE:___________________________
Name
___________________________
Address
Authorization is hereby granted to release to Western Kentucky University (WKU) researchers: Dr. Elizabeth Jones,
Shanna Bowers, and Brooke Wootton, and Psychological Assessment Resources (PAR) researchers such
information relative to service rendered.
(4) ___________________________
Signature of Parent
___________________________
Address
___________________________

(5) ____________________________
Witness
Information particularly requested is listed below:
Your Childs:
Age
Gender
Race
Primary DSM-IV Diagnosis
List of Current Medications
Family History of DSM-IV Diagnosis

___________________________
Date
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As mentioned before, the purpose of this study is to use self-report measures to identify social
and emotional well-being in adolescents. To ensure that the participants of this study meet
diagnosis criteria, it is necessary to obtain diagnosis information from a clinician.
Attached is a release form that must be completed so that your child’s therapist can release
diagnosis and medication information to the researchers.
•

Fill in the name of your child’s therapist at #1

•

Put today’s date at #2

•

Put your child’s name at #3

•

Sign your name, provide address and date at #4

•

Have a witness (someone over 18 years of age) sign at #5
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Participation Assent Form
I have read and understand the information provided about this study. I give assent to participate
in this study conducted by Shanna Bowers, Brooke Wootton, and Dr. Elizabeth Jones of Western
Kentucky University. I understand that I may withdraw from this study at any time without
penalty.
I, ________________________, understand that my parent/guardian has given permission for
me to participate in a study concerning social and emotional well-being, under the direction of
Western Kentucky University.
My participation in this project is completely voluntary, and I understand that I may stop my
participation in this study at any time. I am aware that I am encouraged to answer all of the
items, even if I am unsure how to respond, and that I hold the right to refuse to answer items. If
I choose not to participate, it will not affect my treatment in any way.
Signature _________________________

Date____________

Clinician Record Form
Clinician Name:_____________________________________

Date: ________________

Age: _____
Please provide the following information for the individual participant being rated/tested.
ID No.: _____________________

Gender: ______ Race/Ethnicity: ____________

Primary DSM-IV Diagnosis(es): _____________________________________________________
Estimated Date of Dx: ______________
Diagnosis made by:

1) ________________
Secondary
DSM-IV
Diagnoses:

Psychologist

Psychiatrist

Pediatrician

Primary care physician

School Personnel

Other: _______________

Estimated Date of Dx: ______

Current?
Yes No

2) ________________

Estimated Date of Dx:_______ Yes No

3) ________________

Estimated Date of Dx: _______ Yes No

Current Psychotropic Medications:

1) ___________________________________________
2) ___________________________________________
3) ___________________________________________

Does either parent or any sibling carry a DSM-IV diagnosis(es)?

No

Yes

If yes, indicate biological relative(s) and respective diagnosis(es):
Mother
Diagnosis( es): ____________________________________________________
Father

Diagnosis( es):_____________________________________________________

Sibling 1

Diagnosis( es):_____________________________________________________

Sibling 2

Diagnosis( es):_____________________________________________________

Sibling 3

Diagnosis( es):_____________________________________________________

Sibling 4

Diagnosis( es):_____________________________________________________

Sibling 5

Diagnosis( es):_____________________________________________________

Appendix B
Non-Referred Packet Forms
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Dear Parent/Guardian,
Your child is invited to participate in a study looking at the usefulness of 3 measures of social
and emotional well-being used with adolescents. This study is being conducted by Shanna
Bowers, Brooke Wootton and Dr. Elizabeth Jones of Western Kentucky University. The results
of the study will be used to determine how well these 3 instruments measure social and
emotional well-being in adolescents.
In addition, the results of this study will be used to evaluate a new instrument that measures
social and emotional well-being. Such data can provide information about the new instrument’s
usefulness and ability to measure what it sets out to measure. If you agree to allow your child’s
responses to be used in this evaluation process, there is a separate consent form included in this
packet that requires your signature. This form will be returned to the test publisher.
Upon your consent and your child’s assent, your child will be asked to complete 3 questionnaires
concerning their thoughts, feelings, and emotions as they relate to their day-to-day functioning.
It will take approximately 25 minutes to complete the three questionnaires.
For your child’s participation in this study he or she will receive a local fast food restaurant
coupon that will not exceed a $2.00 value.
Your consent and your child’s participation are completely voluntary. At any time withdrawal
from the study is possible. If you do not consent for your child to participate, it will have no
negative outcomes for you or your child. There are no physical risks involved in filling out the
questionnaires. However, answering the items on the questionnaires may cause your child to feel
some emotional discomfort, due to the nature of the questions asked about your child’s behavior.
All information collected in this study will be kept strictly confidential and will be accessible
only to the project staff. However, all packets will be coded to allow for identification only if an
individual's responses indicate a threat to self or others on the questionnaires. Researchers must
by law report this information to you immediately.
The procedures in this study have been reviewed and approved by the Western Kentucky
University Human Subjects Review Board. If you have questions about the study you may
contact Dr. Elizabeth Jones by phone at (270) 745-4414. We hope that both you and your child
agree to take part in our study. To indicate your consent for participation please complete and
sign the attached form.
Sincerely,
Elizabeth L. Jones
Associate Professor of Psychology

Shanna Bowers
Brooke Wootton
School Psychology Graduate Students
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Participation Consent Form
Child’s Age ____

Child’s Gender __ M __F

Child’s Race/Ethnicity________

I have read the information provided concerning this study. I give consent for my child to
participate in this study conducted by Shanna Bowers, Brooke Wootton, and Dr. Elizabeth Jones
of Western Kentucky University. I understand that I may withdraw from the study at any time
without penalty.
_____ I DO give consent for my child to participate in this study.
_____ I DO NOT give consent for my child to participate in this study.
Parent/Guardian Signature_______________________________ Date __________
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Participation Assent Form
I have read and understand the information provided about this study. I give assent to participate
in this study conducted by Shanna Bowers, Brooke Wootton, and Dr. Elizabeth Jones of Western
Kentucky University. I understand that I may withdraw from this study at any time without
penalty.
I, ________________________, understand that my parent/guardian has given permission for
me to participate in a study concerning social and emotional well-being, under the direction of
Western Kentucky University.
My participation in this project is completely voluntary, and I understand that I may stop my
participation in this study at any time. I am aware that I am encouraged to answer all of the
items, even if I am unsure how to respond, and that I hold the right to refuse to answer items.
Whether or not I choose to participate, I will not be affected in any way.
Signature _________________________

Date____________

Appendix C
Letter of Human Subjects Review Board Approval
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WESTERN KENTUCKY UNIVERSITY
Human Subjects Review Board
Office of Sponsored Programs
104 Foundation Building
270-745-4652; Fax 270-745-4211
E-mail: Phillip.Myers@Wku.Edu
In future correspondence please refer to HS03-077, April 3, 2003
Shanna Bowers
1500 Crossbreeze Ct.
Bowling Green, KY 42104
Dear Shanna:
Your research project, "Concurrent Validity of Adolescent Depression Measures," was reviewed by the
HSRB and it has been determined that risks to subjects are: (1) minimized and reasonable; and that (2)
research procedures are consistent with a sound research design and do not expose the subjects to
unnecessary risk. Reviewers determined that: (1) benefits to subjects are considered along with the
importance of the topic and that outcomes are reasonable; (2) selection of subjects is equitable; and (3)
the purposes of the research and the research setting is amenable to subjects' welfare and producing
desired outcomes; that indications of coercion or prejudice are absent, and that participation is clearly
voluntary.
1. In addition, the IRB found that: (1) signed informed consent will be obtained from all subjects. (2)
Provision is made for collecting, using and storing data in a manner that protects the safety and privacy of
the subjects and the confidentiality of the data. (3) Appropriate safeguards are included to protect the
rights and welfare of the subjects. (4) Any ad or flyer used to recruit participants must be reviewed
by the HSRB before used.
a. Your research therefore meets the criteria of Full Board Review and is Approved.
2. Please note that the institution is not responsible for any actions regarding this protocol before
approval. If you expand the project at a later date to use other instruments please re-apply. Copies of your
request for human subjects review, your application, and this approval, are maintained in the Office of
Sponsored Programs at the above address. Please report any changes to this approved protocol to this
office. A Continuing Review protocol will be sent to you in the future to determine the status of the
project.
Sincerely,
Phillip E. Myers, Ph.D.
Director, OSP and
Human Protections Administrator
cc: Human Subjects File HS03-077
cc: Brooke Wootton
cc: Dr. Elizabeth Jones

